Invention Grant
- Patent Title: Adrenomedullin to guide therapy of blood pressure decline
-
Application No.: US14778114Application Date: 2014-03-19
-
Publication No.: US10598674B2Publication Date: 2020-03-24
- Inventor: Andreas Bergmann
- Applicant: SphingoTec GmbH
- Applicant Address: DE Hennigsdorf
- Assignee: SphingoTec GmbH
- Current Assignee: SphingoTec GmbH
- Current Assignee Address: DE Hennigsdorf
- Agency: Millen, White, Zelano & Branigan, PC
- Agent Ryan Pool
- Priority: EP13160265 20130320
- International Application: PCT/EP2014/055554 WO 20140319
- International Announcement: WO2014/147153 WO 20140925
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/26 ; G01N33/68 ; G01N33/74

Abstract:
Subject matter of the present invention is an in vitro method for identifying a subject in need of administration of fluid resuscitation or a vasopressor comprising the following steps: Determining the level of proADM and/or fragments thereof having at least 6 amino acids in a bodily fluid of said subject Correlating said level with the need of said patient for fluid resuscitation or administration of a vasopressor wherein said patient is identified as having such a need if the level of proADM and/or fragments thereof having at least 6 amino acids in the bodily fluid of said subject is above a threshold.
Public/Granted literature
- US20170010286A1 ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE Public/Granted day:2017-01-12
Information query